RMRyo Matsunaga

Ryo Matsunaga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ryo Matsunaga has a total of 31 co-authors. Here are the top co-authors by number of shared publications:

  • Kouhei Tsumoto

    Department of Bioengineering, School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan

    16 shared publications
  • Satoru Nagatoishi

    The University of Tokyo

    8 shared publications
  • Makoto Nakakido

    Department of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, Bunkyo-ku, Tokyo, Japan; Department of Bioengineering, School of Engineering, The University of Tokyo, Bunkyo-ku, Tokyo, Japan

    6 shared publications
  • Daisuke Kuroda

    Department of Biosciences, College of Humanities and Sciences, Nihon University, 3-25-40, Sakurajosui, Setagaya-ku, Tokyo, 156-8550, Japan

    5 shared publications
  • Makoto Nakakido

    Department of Bioengineering, School of Engineering, The University of Tokyo, Bunkyo-ku, Tokyo, Japan; Department of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, Bunkyo-ku, Tokyo, Japan

    3 shared publications
  • Chinatsu Mori

    Department of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan

    2 shared publications

Latest Publications

  • Open Access

    Chemically encoded pH-tunable covalent adhesion by a bacterial thioester domain

    by Yuki Tokunaga, Ryo Matsunaga, Hiroko Kozuka-Hata, Masaaki Oyama, Kouhei Tsumoto

    Thioester domains (TEDs) represent a family of bacterial adhesin domains that mediate covalent anchoring to target ligands via an intramolecular thioester bond. Although the broad distribution of TEDs among Gram-positive bacteria suggests a critical functional role, the biological significance of this covalent mechanism remains unclear. In this study, we demonstrated that TED-mediated covalent anchoring is reversible and that its equilibrium is regulated by pH. Specifically, SfbI-TED from group A Streptococcus binds tightly to fibrinogen at physiological pH, whereas mild acidification to pH 6.0 induces rapid dissociation of the complex. Thermodynamic analyses indicated that this pH responsiveness is largely dictated by the intrinsic pH sensitivity of the thioester-mediated acyl transfer reaction conserved within TEDs, rather than by surface residues specific to individual TEDs. Similar pH-dependent behavior was observed in phylogenetically distinct TEDs, suggesting that pH-responsive adhesion is likely to be a broadly shared feature of TED-containing adhesins across Gram-positive bacteria.

  • Open Access

    MAXTIA : A high‐throughput platform for rapid functional epitope mapping by kinetic screening of mutant libraries

    by Kihoon Kim, Ryo Matsunaga, Takanori Yokoo, Makoto Nakakido, Kouhei Tsumoto

    Accurate identification of epitope residues is essential for developing biopharmaceuticals and understanding the mechanisms of immune recognition. However, experimental approaches for residue‐level epitope mapping remain time‐consuming and labor‐intensive, while accurate computational prediction of protein–protein interfaces remains challenging. Here, we present MAXTIA, a high‐throughput kinetic screening platform that integrates cell‐free protein synthesis with high‐throughput surface plasmon resonance and demonstrate its application to alanine scanning‐based functional epitope mapping. This workflow enables the rapid preparation and kinetic characterization of up to 384 protein variants, allowing the identification of functional epitope residues within 3 days while simultaneously providing binding affinity and kinetic parameters ( K D , k on , and k off ). We applied MAXTIA to map the epitope of the single‐domain antibody (VHH) N1 against the pentraxin domain of neuronal pentraxin‐2 (NP2 PTX). Alanine substitutions that cause substantial affinity losses clustered within a localized region on the AlphaFold3‐predicted NP2 PTX structure, defining a functional epitope site. These residues closely matched the interface observed in the NP2 PTX–VHH N1 crystal structure, validating the accuracy of MAXTIA. Beyond epitope identification, MAXTIA provides a simple and versatile platform for the quantitative analysis of protein–protein interactions, including high‐throughput screening of antibody variants for affinity optimization. This approach should accelerate biopharmaceutical development and facilitate mechanistic studies of molecular recognition.

  • Open Access

    Chemically encoded pH-tunable covalent adhesion by a bacterial thioester domain

    by Yuki Tokunaga, Ryo Matsunaga, Hiroko Kozuka-Hata, Masaaki Oyama, Kouhei Tsumoto

    Thioester domains (TEDs) represent a family of bacterial adhesin domains that mediate covalent anchoring to target ligands via an intramolecular thioester bond. Although the broad distribution of TEDs among Gram-positive bacteria suggests a critical functional role, the biological significance of this covalent mechanism remains unclear. In this study, we demonstrated that TED-mediated covalent anchoring is reversible and that its equilibrium is regulated by pH. Specifically, SfbI-TED from Group A Streptococcus binds tightly to fibrinogen at physiological pH, whereas mild acidification to pH 6.0 induces rapid dissociation of the complex. Thermodynamic analyses revealed that this pH-responsiveness arises from the intrinsic properties of the thioester bond within the TED. Similar pH-dependent behavior was observed in phylogenetically distinct TEDs, suggesting that pH-responsive adhesion is a conserved feature of the TED family across Gram-positive bacteria.

  • Open Access

    Accelerating antibody discovery and optimization with high-throughput experimentation and machine learning

    by Ryo Matsunaga, Kouhei Tsumoto

    The integration of high-throughput experimentation and machine learning is transforming data-driven antibody engineering, revolutionizing the discovery and optimization of antibody therapeutics. These approaches employ extensive datasets comprising antibody sequences, structures, and functional properties to train predictive models that enable rational design. This review highlights the significant advancements in data acquisition and feature extraction, emphasizing the necessity of capturing both sequence and structural information. We illustrate how machine learning models, including protein language models, are used not only to enhance affinity but also to optimize other crucial therapeutic properties, such as specificity, stability, viscosity, and manufacturability. Furthermore, we provide practical examples and case studies to demonstrate how the synergy between experimental and computational approaches accelerates antibody engineering. Finally, this review discusses the remaining challenges in fully realizing the potential of artificial intelligence (AI)-powered antibody discovery pipelines to expedite therapeutic development.


  • Open Access

    Affinity‐stability trade‐off mechanism of residue 35 in framework region 2 of VHH antibodies with β‐hairpin CDR3

    by Koichi Yamamoto, Satoru Nagatoishi, Ryo Matsunaga, Makoto Nakakido, Daisuke Kuroda, Kouhei Tsumoto

    Single‐domain VHH antibodies are promising therapeutic and diagnostic tools. The third complementarity‐determining region (CDR3) is usually the most critical region for antigen recognition by VHH antibodies. When CDR3 adopts a short and extended β‐hairpin conformation, framework region 2 (FR2) often interacts directly with the antigen. However, the importance of these interactions in antigen recognition remains unclear. In this research, we investigated the role of FR2 residues in VHH antibodies with β‐hairpin CDR3s. We found that several FR2 residues, particularly at positions 35 and 37, are critical for high‐affinity antigen binding. Notably, a trade‐off was observed: introducing a charged residue at position 35 enhanced binding affinity but reduced thermal stability. These findings provide insights into optimizing FR2 in single‐domain antibodies to improve their functionality for diagnostic and therapeutic applications.


  • Open Access

    FASTIA: A rapid and accessible platform for protein variant interaction analysis demonstrated with a single‐domain antibody

    by Ryo Matsunaga, Kouhei Tsumoto

    Antibodies are critical tools in medicine and research, and their affinity for their target antigens is a key determinant of their efficacy. Traditional antibody affinity maturation and interaction analyses are often hampered by time‐consuming steps such as cloning, expression, purification, and interaction assays. To address this, we have developed FASTIA (Fast Affinity Screening Technology for Interaction Analysis), a novel platform that integrates rapid gene fragment preparation, cell‐free protein synthesis, and bio‐layer interferometry with non‐regenerative analysis. Using this approach, we can analyze the intermolecular interactions of over 20 variants over 2 days, requiring only the parent protein expression plasmid and basic equipment. We have demonstrated the ability of FASTIA to discriminate between single‐domain antibody variants with different binding affinities using the anti‐HEL VHH antibody D2‐L29, and mapped the results to the crystal structure to identify key interaction sites. FASTIA provides results comparable to those obtained using traditional methods. Our system bypasses the need for genetic engineering facilities and can be easily adopted by laboratories, accelerating the protein engineering and optimization processes. In addition, FASTIA is applicable to other protein–protein interactions, making it a versatile tool for studying molecular recognition. FASTIA facilitates efficient affinity maturation, protein engineering, and analysis of protein–protein interactions. This provides a rapid and accessible route for improving antibodies and a broader understanding of protein interactions.


  • Open Access

    Unveiling the structural mechanisms behind high affinity and selectivity in phosphorylated epitope-specific rabbit antibodies

    by Keisuke Kasahara, Raiji Kawade, Makoto Nakakido, Ryo Matsunaga, Hiroki Akiba, Kevin C. Entzminger, Toshiaki Maruyama, Shigeru C.J. Okumura, Jose M.M. Caaveiro, Daisuke Kuroda, et al.


  • Open Access

    High‐throughput system for the thermostability analysis of proteins

    by Sae Ito, Ryo Matsunaga, Makoto Nakakido, Daisuke Komura, Hiroto Katoh, Shumpei Ishikawa, Kouhei Tsumoto

    Thermal stability of proteins is a primary metric for evaluating their physical properties. Although researchers attempted to predict it using machine learning frameworks, their performance has been dependent on the quality and quantity of published data. This is due to the technical limitation that thermodynamic characterization of protein denaturation by fluorescence or calorimetry in a high‐throughput manner has been challenging. Obtaining a melting curve that derives solely from the target protein requires laborious purification, making it far from practical to prepare a hundred or more samples in a single workflow. Here, we aimed to overcome this throughput limitation by leveraging the high protein secretion efficacy of Brevibacillus and consecutive treatment with plate‐scale purification methodologies. By handling the entire process of expression, purification, and analysis on a per‐plate basis, we enabled the direct observation of protein denaturation in 384 samples within 4 days. To demonstrate a practical application of the system, we conducted a comprehensive analysis of 186 single mutants of a single‐chain variable fragment of nivolumab, harvesting the melting temperature (Tm) ranging from −9.3 up to +10.8°C compared to the wild‐type sequence. Our findings will allow for data‐driven stabilization in protein design and streamlining the rational approaches.


  • Open Access

    Generation of antibodies to an extracellular region of the transporters Glut1/Glut4 by immunization with a designed antigen

    by Taichi Sumikawa, Makoto Nakakido, Ryo Matsunaga, Daisuke Kuroda, Satoru Nagatoishi, Kouhei Tsumoto